“…High serum concentrations of cTnI occur in horses with ventricular tachyarrhythmias, monensin toxicosis, atypical myopathy, atrial fibrillation, structural heart disease, and amyloidosis [3,6,7,8]. cTnI is also increase with non-cardiac diseases that induces secondary cardiac involvement, as example with babesiosis and endotoxaemia [9,10]. Release of cTnI during and after exercise also has been described in equine athletes after racing or race training, endurance rides or treadmill exercise [11,12,14,13].…”